City

Badajoz (1)

Beijing (1)

Milan (1)

Condition

Disease Free Survival (3)

Overall Survival (2)

Pancreatic Cancer (1)

Pathological Complete Response (1)

Rectal Cancer (1)

Surgical Procedure (1)

Overall Status

Unknown status (2)

Recruiting (1)

Phase

phase 2 (1)

Sponsor

Massimo Falconi (1)

Peking University People's Hospital (1)

Universidad de Extremadura (1)

Intervention

concurrent capecitabine-based long-term radiotherapy followed by 4 cycles xelox and a delayed tme (1)

concurrent capecitabine-based long-term radiotherapy followed by a regular tme and 6 cycles xelox (1)

use of targeted drugs such as aspirin, b-blockers, metformin, ace-inhibitors, statins (1)

Study Documents

Intervention Type

behavioral (1)

drug (1)

Funder Type

Other (3)

Study Type

Interventional (1)

Observational (1)

Observational [Patient Registry] (1)

disease free survival

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Disease Free Survival, Overall Survival, Pancreatic Cancer Trial in Milan (use of targeted drugs such as aspirin, B-Blockers,

Recruiting

Disease Free Survival
+2 more

use of targeted drugs such as aspirin, B-Blockers, Metformin, ACE-inhibitors, Statins

Milan, Italy

IRCCS San Raffaele

Mar 7, 2022

Pancreatic Metastases From Renal Cell Carcinoma

Unknown status

Surgical Procedure
+2 more

Badajoz, Spain

Gerardo Blanco-Fernández

Nov 2, 2020

Rectal Cancer, Pathological Complete Response, Disease Free Survival Trial in Beijing (concurrent capecitabine-based long-term

Unknown status

Rectal Cancer
+2 more

concurrent capecitabine-based long-term radiotherapy followed by 4 cycles XELOX and a delayed TME
concurrent capecitabine-based long-term radiotherapy followed by a Regular TME and 6 Cycles XELOX

Beijing, Beijing, China
+1 more

May 17, 2020